Grid Therapeutics

Grid Therapeutics is an emerging clinical-stage biotechnology company located in Durham, North Carolina. We are committed to developing better and safer cancer therapeutic antibodies for patients and their families. Grid has a unique and innovative platform for discovering human antibodies targeting novel tumor-specific markers, and rapidly translating these discoveries into clinical practice. The management team is structured to quickly advance these assets into clinical trials, with the skills and experience to deliver a unique portfolio of products in the immuno-oncology field. The board has a deep understanding of the current state of oncology and is prepared to support the management team in formulating effective and impactful development plans.